Sabine Werner

Sabine Werner (born September 5, 1960 in Tübingen ) is a German biochemist and professor of cell biology at the ETH Zurich .

Sabine Werner studied in Tübingen , Martinsried and Munich , where she did her doctorate in 1989 with Peter Hans Hofschneider with a dissertation on the molecular pathogenesis of Kaposi's sarcoma . She was awarded the Otto Hahn Medal for her achievements in her doctorate . As a post-doctoral student , she was at the University of California in San Francisco from 1990 to 1992 ; In 1993 she took on the role of working group leader and Hermann and Lilly Schilling professor at the Max Planck Institute for Biochemistry . She completed her habilitation in 1995 with a paper on the function of fibroblast growth factors in the skin. She worked in Martinsried until 1999 when she took up her full professorship in Zurich.

Her work focuses on the role of growth factors in wound healing and cancer .

In 1997 she was one, next Domdey , one of the founders of the previous bankruptcy in September 2004 in Biotech - startups Switch Biotech AG . She has been a member of the Leopoldina since 2011 . In 2012 she was elected a member of the European Molecular Biology Organization . She is also a member of the jury for the Hofrichter research award of the Zurich Foundation for Experimental Biomedicine .

In 2008 she received the Cloëtta Prize .

Web links

• "Professors at ETH Zurich" , p. 46 f., Portrait of Sabine Werner from April 2003 (PDF file; 1.61 MB)
• CV at ETH Zurich
• Publications by the Werner working group at ETH Zurich
• Sabine Werner in the database of renowned academics AcademiaNet

Individual evidence

1. ↑ Member entry of Sabine Werner (with picture) at the German Academy of Natural Scientists Leopoldina , accessed on July 20, 2016.
2. ↑ Peter Hans Hofschneider Research Prize for Science and Medical Journalism , Foundation for Experimental Biomedicine, accessed July 28, 2016